A dangerous drug injury case generally looks at whether a medication’s risks were properly disclosed, whether it was made and distributed using appropriate safety and quality practices, and whether the product was reasonably safe for its intended use. The heart of these cases is not the fact that someone got sick after taking a drug. The legal question is whether the drug was defective or unreasonably dangerous in a way that contributed to the harm, considering what was known at the time.
In New Mexico, medication injuries can affect people in every setting, from urban medical centers to rural communities where specialist access may be limited. That can influence how quickly symptoms are recognized, how records are gathered, and how difficult it may be to obtain the right expert review. These are solvable challenges, but they require planning and attention to detail.
Many claims focus on inadequate warnings, labeling that failed to communicate key risk information, or manufacturing and quality problems that caused the medication to be unsafe as produced. Other cases involve situations where the medication’s safety profile did not match the information provided to patients and healthcare providers. A strong claim connects the medication timeline to the medical evidence and then to the legal elements of responsibility.


